Production of IBDV VP2 in highly immunogenic form

A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural prote...

Full description

Saved in:
Bibliographic Details
Main Authors FAHEY; KEVIN J, JAGADISH; MITTUR N, HEINE; HANS-GEORG, CHAPMAN; ANTONY J, AZAD; AHMED A, VAUGHAN; PAUL R, MACREADIE; IAN G, MCKERN; NEIL M
Format Patent
LanguageEnglish
Published 25.03.1997
Edition6
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell.
Bibliography:Application Number: US19940182402